Bioengineering Advances Offer Promise for Skin Regeneration

This article originally appeared here.
Share this content:
Bioengineering Advances Offer Promise for Skin Regeneration
Bioengineering Advances Offer Promise for Skin Regeneration

FRIDAY, April 1, 2016 (HealthDay News) -- An in vivo transplantation model has been used to develop a three-dimensional (3D) integumentary organ system from induced pluripotent stem cells, according to research published online April 1 in Science Advances.

Ryoji Takagi, from the Tokyo University of Science, and colleagues developed a novel in vivo transplantation model designated as a clustering-dependent embryoid body transplantation method. Using induced pluripotent stem cells, they generated a 3D integumentary organ system, which included appendage organs such as hair follicles and sebaceous glands.

The researchers found that following transplantation into nude mice, the bioengineered organ system was fully functional and could be properly connected to surrounding host tissues, such as the epidermis, arrector pili muscles, and nerve fibers, without tumorigenesis. Within the 3D integumentary organ system, the bioengineered hair follicles showed proper hair eruption and hair cycles, which included rearrangement of follicular stem cells and their niches.

"Potential applications of the 3D integumentary organ system include an in vitro assay system, an animal model alternative, and a bioengineered organ replacement therapy," the authors write.

Two authors are employees of Organ Technologies, which partially funded the study.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Incident Contrast Sensitivity Common in Middle-Aged Adults

Incident Contrast Sensitivity Common in Middle-Aged Adults

Factors linked to elevated risk include cadmium level in highest quintile, older age, more plaque sites

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Tafamidis Treats Transthyretin Amyloid Cardiomyopathy

Reduces all-cause mortality, cardiovascular-related hospitalizations compared with placebo

Scribes Improve Physician Workflow, Patient Interaction

Scribes Improve Physician Workflow, Patient Interaction

Scribes lower EHR documentation burden for doctors and increase time spent interacting with patients

is free, fast, and customized just for you!




Already a member?

Sign In Now »